Hughes is an attorney and advisor in the biopharma sector.

It's going to become unnecessarily harder to develop and make new vaccines. I've witnessed firsthand the dynamic nature of the vaccine industry, especially during my tenure at Moderna. It's a rocky business that is dealing with a rapidly occurring negative shift.

During the COVID pandemic, companies navigated market uncertainty while rushing to develop, test, and manufacture vaccines. A big difference maker was a national demand and collective understanding of the public health need for vaccines -- we all wanted to get out of our homes and back to our daily lives. The corresponding purchase commitments those companies secured with unprecedented government partnership made it viable for them to step forward and produce vaccines in

See Full Page